oral semaglutide for obesity IGR: New weight-loss pill beats Ozempic in major trial A once-daily weight-loss pill, orforglipron, has outperformed the leading oral in a major Phase 3 clinical trial involving adults with Type Amanda Bonello interviews Sabina SIZE:30mg firm

oral semaglutide for obesity IGR: New weight-loss pill beats Ozempic in major trial A once-daily weight-loss pill, orforglipron, has outperformed the leading oral in a major Phase 3 clinical trial involving adults with Type Amanda Bonello interviews Sabina SIZE:30mg firm

Amanda Bonello interviews Sabina Hemmi, founder of GLP Winner, about the Safe Drugs Act and state bills threatening compounded GLP-1 access, including semaglutide and tirzepatide, and what patients can do to protect

Nogrady B (2026)

firm

SIZE:30mg

The STEP 4 extension showed about two-thirds of weight lost was regained within a year of stopping semaglutide